Preparation and physicochemical characterization of spray-dried and jet-milled microparticles containing bosentan hydrate for dry powder inhalation aerosols

References

• RubinLJBadeschDBBarstRJBosentan therapy for pulmonary arterial hypertensionN Engl J Med20023461289690311907289
   PubMed Web of Science ®Google Scholar
• FarberHWLoscalzoJPulmonary arterial hypertensionN Engl J Med2004351161655166515483284
   PubMed Web of Science ®Google Scholar
• MotteSMcEnteeKNaeijeREndothelin receptor antagonistsPharmacol Ther2006110338641416219361
   PubMed Web of Science ®Google Scholar
• GuptaVGuptaNShaikIHInhaled PLGA particles of prostaglandin E1 ameliorate symptoms and progression of pulmonary hypertension at a reduced dosing frequencyMol Pharm20131051655166723485062
   PubMed Web of Science ®Google Scholar
• GuptaVAhsanFInhalational therapy for pulmonary arterial hypertension: current status and future prospectsCrit Rev Ther Drug Carrier Syst201027431337020932241
   PubMed Web of Science ®Google Scholar
• VaidyaBGuptaVNovel therapeutic approaches for pulmonary arterial hypertension: unique molecular targets to site-specific drug deliveryJ Control Release201521111813326036906
   PubMed Web of Science ®Google Scholar
• HoeperMHalankMMarxCBosentan therapy for portopulmonary hypertensionEur Respir J200525350250815738295
   PubMed Web of Science ®Google Scholar
• GradonLSosnowskiTRFormation of particles for dry powder inhalersAdv Powder Technol20142514355
   Web of Science ®Google Scholar
• ChenLOkudaTLuX-YChanH-KAmorphous powders for inhalation drug deliveryAdv Drug Deliv Rev201610010211526780404
   PubMed Web of Science ®Google Scholar
• CuvelierBEloyPLoira-PastorizaCMinimal amounts of dipalmitoylphosphatidylcholine improve aerosol performance of spray-dried temocillin powders for inhalationInt J Pharm2015495298199026456267
   PubMedGoogle Scholar
• ParkC-WLiXVogtFGAdvanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosolsInt J Pharm2013455137439223820131
   PubMedGoogle Scholar
• WeersJInhaled antimicrobial therapy–barriers to effective treatmentAdv Drug Deliv Rev201585244325193067
   PubMed Web of Science ®Google Scholar
• ChowAHTongHHChattopadhyayPShekunovBYParticle engineering for pulmonary drug deliveryPharm Res200724341143717245651
   PubMed Web of Science ®Google Scholar
• PilcerGAmighiKFormulation strategy and use of excipients in pulmonary drug deliveryInt J Pharm2010392111920223286
   PubMedGoogle Scholar
• HeyderJGebhartJRudolfGSchillerCFStahlhofenWDeposition of particles in the human respiratory tract in the size range 0.005–15 μmJ Aerosol Sci1986175811825
   Web of Science ®Google Scholar
• SouTMeeusenENDe VeerMMortonDAKaminskasLMMcIntoshMPNew developments in dry powder pulmonary vaccine deliveryTrends Biotechnol201129419119821255854
   PubMed Web of Science ®Google Scholar
• ZhangJWuLChanH-KWatanabeWFormation, characterization, and fate of inhaled drug nanoparticlesAdv Drug Deliv Rev201163644145521118707
   PubMed Web of Science ®Google Scholar
• DjokićMKachrimanisKSolomunLDjurišJVasiljevićDIbrićSA study of jet-milling and spray-drying process for the physicochemical and aerodynamic dispersion properties of amiloride HClPowder Technol2014262170176
   Web of Science ®Google Scholar
• PalaniandySAzizliKAMHussinHHashimSFSEffect of operational parameters on the breakage mechanism of silica in a jet millMiner Eng2008215380388
   Web of Science ®Google Scholar
• MidouxNHošekPPailleresLAuthelinJMicronization of pharmaceutical substances in a spiral jet millPowder Technol19991042113120
   Web of Science ®Google Scholar
• FiegelJGarcia-ContrerasLThomasMPreparation and in vivo evaluation of a dry powder for inhalation of capreomycinPharm Res200825480581117657592
   PubMed Web of Science ®Google Scholar
• YangYTsifanskyMDWuC-JYangHISchmidtGYeoYInhalable antibiotic delivery using a dry powder co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosisPharm Res201027115116019847626
   PubMed Web of Science ®Google Scholar
• MeenachSAAndersonKWHiltJZMcGarryRCMansourHMCharacterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancerEur J Pharm Sci201349469971123707466
   PubMed Web of Science ®Google Scholar
• MooreJWFlannerHHMathematical comparison of dissolution profilesPharm Technol19962066474
   Google Scholar
• De BoerAHagedoornPGjaltemaDGoedeJKussendragerKFrijlinkHAir classifier technology (ACT) in dry powder inhalation part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalationInt J Pharm2003260220121612842340
   PubMed Web of Science ®Google Scholar
• MannamRYallamalliIMFormulation and evaluation of matrix membrane moderated transdermal patches of bosentan monohydrateInt J Sci Eng Res2015610746755
   Google Scholar
• WigginsNAThe development of a mathematical approximation technique to determine the mass median aerodynamic diameter (MMAD) and geometric standard deviation (GSD) of drug particles in an inhalation aerosol spratDrug Dev Ind Pharm1991171419711986
   Web of Science ®Google Scholar
• ShekunovBYChattopadhyayPTongHHChowAHParticle size analysis in pharmaceutics: principles, methods and applicationsPharm Res200724220322717191094
   PubMed Web of Science ®Google Scholar
• MaySJensenBWolkenhauerMSchneiderMLehrCMDissolution techniques for in vitro testing of dry powders for inhalationPharm Res20122982157216622528980
   PubMed Web of Science ®Google Scholar
• KawakamiKSumitaniCYoshihashiYYonemochiETeradaKInvestigation of the dynamic process during spray-drying to improve aerodynamic performance of inhalation particlesInt J Pharm2010390225025920170721
   PubMedGoogle Scholar
• TawfeekHMEvansARIftikharADry powder inhalation of macromolecules using novel PEG-co-polyester microparticle carriersInt J Pharm2013441161161923124106
   PubMedGoogle Scholar
• MouraCNevesFCostaEImpact of jet-milling and wet-polishing size reduction technologies on inhalation API particle propertiesPowder Technol20162989098
   Web of Science ®Google Scholar
• KubavatHAShurJRuecroftGHipkissDPriceRInfluence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalationInt J Pharm20124301263322449413
   PubMedGoogle Scholar
• ChewNYChanH-KUse of solid corrugated particles to enhance powder aerosol performancePharm Res200118111570157711758765
   PubMed Web of Science ®Google Scholar
• PhilipVAMehtaRCMazumderMKDeLucaPPEffect of surface treatment on the respirable fractions of PLGA microspheres formulated for dry powder inhalersInt J Pharm19971512165174
   Google Scholar
• Task Group on Lung DynamicsDeposition and retention models for internal dosimetry of the human respiratory tractHealth Phys19661221732075916786
   PubMed Web of Science ®Google Scholar
• HickeyAJMansourHMTelkoMJPhysical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristicsJ Pharm Sci20079651282130117455324
   PubMed Web of Science ®Google Scholar
• DolovichMBJordanaMNewhouseMTMethodologic considerations in mucociliary clearance and lung epithelial absorption measurementsEur J Nucl Med1987131S45S523609065
   PubMedGoogle Scholar
• Ei-AriniSKLeuenbergerHModelling of drug release from polymer matrices: effect of drug loadingInt J Pharm19951212141148
   Google Scholar
• DaviesNMFeddahMRA novel method for assessing dissolution of aerosol inhaler productsInt J Pharm2003255117518712672613
   PubMedGoogle Scholar
• SinghviGSinghMReview: in-vitro drug release characterization modelsInt J Pharm Stud Res2011217784
   Google Scholar